Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Motor Activity 4Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Obesity 2Colorectal Neoplasms 2Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Skin Neoplasms 1Sarcopenia 1Renal Insufficiency, Chronic 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Overweight 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Multiple Myeloma 1Melanoma 1Lymphoma 1Lung Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Inflammation 1Hematopoietic and Lymphatic System Neoplasm 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Megestrol Acetate 2Counseling 2semaglutide 1Tirzepatide 1Tablets 1Resistance Training 1Progestins 1Nutrition Assessment 1Methods 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Hysteroscopy 1Estrogen Replacement Therapy 1Educational Status 1Early Intervention, Educational 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Overweight × Resistance Training × 90 days × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡